ArticleTherapeutic advances in urology

Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.

Elodie Coquan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.